Clinical trials
Recruiting Lymphoma trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
68 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 7 |
| 2023 | 11 |
| 2024 | 11 |
| 2025 | 19 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 68 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 6 |
| Ruijin Hospital | 4 |
| Chinese PLA General Hospital | 3 |
| Essen Biotech | 2 |
| Hebei Senlang Biotechnology Inc., Ltd. | 2 |
| Liping Dou | 2 |
| Peking University First Hospital | 2 |
| The First Affiliated Hospital of Xiamen University | 2 |
| Affiliated Hospital of Nantong University | 1 |
| Affiliated Hospital to Academy of Military Medical Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 68 |
| Multiple Myeloma | 11 |
| Leukemia, Myeloid, Acute | 9 |
| Recurrence | 7 |
| Leukemia | 6 |
| Lymphoma, Non-Hodgkin | 5 |
| Hematologic Neoplasms | 4 |
| Lymphoma, Follicular | 4 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Myelodysplastic Syndromes | 3 |
Trials
Showing 1 to 25 of 68. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.